Trial site
Oncology Associates of Oregon, P.C.
- 16running trials
- 3closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Diffuse large B-cell lymphoma3 trials
- Ovarian cancer3 trials
- Metastatic breast cancer2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Head and neck cancer1 trial
- Hodgkin lymphoma1 trial
- and 2 more
- Phase
- Phase 311 trials
- Phase 24 trials
- Phase 1/23 trials
- Phase 2/31 trial
- Status
- Active, not recruiting8 trials
- Recruiting8 trials
- Completed3 trials
- Lead sponsor
- Pfizer6 trials
- Hoffmann-La Roche5 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Daiichi Sankyo1 trial
- Faeth Therapeutics1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Recruiting
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Bladder cancer1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Follicular lymphoma1 recruiting
- Hodgkin lymphoma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026